Burkitt's lymphoma

@article{Molyneux2012BurkittsL,
  title={Burkitt's lymphoma},
  author={Elizabeth M Molyneux and Rosemary Rochford and Beverly E. Griffin and Rob Newton and Graham Jackson and Geetha Menon and Christine J Harrison and Trijn Israels and Simon Bailey},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={1234-1244}
}

Figures and Tables from this paper

Burkitt and Burkitt-Like Lymphoma
TLDR
Although the tumor is highly aggressive, being the most rapidly growing cancer known and doubling every 24 h, it is also very responsive to modern chemotherapy.
Burkitt and Burkitt-Like Lymphomas: a Systematic Review
TLDR
Rituximab-based short-course dose-intensive chemotherapy is the standard of care of Burkitt’s lymphoma even in the immunodeficiency-related form.
Adult Burkitt Lymphoma and Leukemia
TLDR
Patients with BL are successfully treated with short intensive regiments including high-dose methotrexate and fractionated cyclophosphamide as major treatment elements, and the inclusion of rituximab into these protocols has contributed to further improvement.
Epstein–Barr Virus and Burkitt’s Lymphoma
TLDR
A review of the critical roles of the EBV latency proteins in oncogenesis and their contribution to cellular proliferation, deregulation of cell signaling and inhibition of the apoptotic process will provide clues to the probable strategies for therapeutic intervention of EBV-associated Burkitt’s lymphoma progression.
The treatment of Burkitt lymphoma in adults.
TLDR
The clinical, pathologic, and genomic features of Burkitt lymphoma, as well as standard and emerging treatment options for adult patients with BL are highlighted.
Burkitt Lymphoma: A Review
TLDR
Burkitt Lymphoma is the fastest growing tumour, characterized by explosive growth with a doubling time of 24 hours, and constitutes 5% of lymphomas for both adult and childhood populations.
HIV-associated Burkitt lymphoma.
Burkitt’s Lymphoma: Physiopathology and Treatment of EBV-Associated Lymphomas
TLDR
Current therapy of eBL yields cure rates in the range of 30–50 %, still largely inferior to the 70–90 % achievable in higher-income countries, and treatment should be proposed.
Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma
TLDR
The potential risks and benefits of commonly used regimens are reviewed, along with a discussion of controversial issues in the practical management of HIV-BL, including concurrent anti-retroviral therapy, treatment of relapsed and/or refractory disease, and the role of stem cell transplantation.
A case of Burkitt's lymphoma detected with tumor cells clustering in urine
TLDR
A case in which BL developed from the retroperitoneal space into the pelvic cavity, with tumor cells appearing in the urine through an invasion of the bladder wall is reported.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 243 REFERENCES
African Burkitt's lymphoma: a new perspective.
  • S. K. Ong, S. Xue, B. Griffin
  • Medicine, Biology
    Transactions of the Royal Society of Tropical Medicine and Hygiene
  • 2001
Burkitt's lymphoma in Africa, a review of the epidemiology and etiology.
TLDR
Evidence for a causal relationship between EBV and BL in the endemic form is fairly strong, and EBV may play a role in the pathogenesis of BL by deregulation of the oncogene c-MYC by chromosomal translocation.
Burkitt's lymphoma.
African Burkitt's lymphoma. History, biology, clinical features, and treatment.
  • I. Magrath
  • Medicine
    The American journal of pediatric hematology/oncology
  • 1991
TLDR
Small, noncleaved cell lymphoma is the latest histological designation of the category of lymphomas that includes Burkitt's lymphoma, which has become notorious because of its high incidence in individuals infected with the human immunodeficiency virus.
Burkitt's lymphoma: clinicopathologic features and differential diagnosis.
TLDR
With the publication of the WHO Classification of Haematopoietic and Lymphoid Tumors, the nomenclature of this lymphoma has come full circle, and it is once again known simply as Burkitt's lymphoma.
Etiology and pathogenesis of AIDS-related non--Hodgkin's lymphoma.
  • D. Knowles
  • Biology, Medicine
    Hematology/oncology clinics of North America
  • 1996
...
1
2
3
4
5
...